Clinical Trials Sponsored by Rocket Pharma Limited
Total 579 results
-
Ludwig-Maximilians - University of MunichRoche Pharma AGUnknown
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
National Taiwan University HospitalRoche Pharma AG; IpsenRecruitingEsophageal Cancer | Metastatic Cancer | Squamous Cell CarcinomaTaiwan
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AGCompletedAdvanced Solid Tumors or Hematologic MalignanciesGermany
-
The Lymphoma Academic Research OrganisationRoche Pharma AGCompleted
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedPulmonary FibrosisFrance
-
Federation Francophone de Cancerologie DigestiveRoche Pharma AGCompleted
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Martin-Luther-Universität Halle-WittenbergRoche Pharma AGCompletedMetastatic Colorectal CancerGermany
-
Fundación Leucemia y Linfoma, SpainRoche Pharma AGCompletedNon-Hodgkin's LymphomaSpain
-
University of PittsburghRoche Pharma AG; Aventis PharmaceuticalsTerminated
-
University of California, San FranciscoRoche Pharma AGCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
University of CologneSanofi; Novartis; Roche Pharma AGCompleted
-
Charite University, Berlin, GermanySanofi; Roche Pharma AGUnknown
-
Peking University Cancer Hospital & InstituteRoche Pharma AGUnknown
-
Zogenix, Inc.Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.TerminatedRefractory Epilepsy | Development DelayGermany, Spain, France, Italy
-
University of Health Sciences LahoreUniversity of Lahore; Amson Vaccine and Pharma (Pvt) LimitedUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRoche Pharma AG; GFPCCompletedSmall Cell Lung CancerFrance
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
King's College LondonRoche Pharma AG; Medical Research CouncilCompletedKidney Transplantation | Graft Rejection | ImmunosuppressionUnited Kingdom
-
Centre Jean PerrinRoche Pharma AG; NanoString Technologies, Inc.Terminated
-
Molecular NeuroImagingRoche Pharma AG; Institute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD)United States
-
Göteborg UniversityThe Swedish Research Council; Roche Pharma AGCompleted
-
University College, LondonRoche Pharma AG; Cancer Research UKTerminatedLung Cancer | Metastatic CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRoche Pharma AGCompletedSystemic Lupus Erythematosus | ANCA Associated VasculitisUnited Kingdom
-
Institut CurieRoche Pharma AG; National Research Agency, FranceNot yet recruitingTriple Negative Breast CancerFrance
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLymphomaNew Zealand, United Kingdom, Australia
-
Ludwig-Maximilians - University of MunichBayer; Roche Pharma AGActive, not recruiting
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
Fundacion SEIMC-GESIDARoche Pharma AG; Dynamic Science S.L.Completed
-
University of British ColumbiaRoche Pharma AG; Health CanadaEnrolling by invitationCovid19 | Asymptomatic Shedding ViralCanada
-
Instituto Valenciano de Infertilidad, IVI VALENCIARoche Pharma AGCompletedInfertility | Controlled Ovarian HyperstimulationSpain
-
Universidad de ValparaisoGlaxoSmithKline; Roche Pharma AG; Aclin LaboratoryCompleted
-
Ohio State University Comprehensive Cancer CenterRoche Pharma AGTerminatedAdenocarcinoma | Tumors | Unknown Primary TumorsUnited States
-
SCRI Development Innovations, LLCRoche Pharma AG; Sanofi-SynthelaboCompletedNeoplasms, Unknown PrimaryUnited States
-
Karolinska University HospitalRoche Pharma AG; Addoz; Tele2Sverige ABCompletedCommunication | Medication Adherence | Medication Nonadherence | Compliance | Transplant; Failure, KidneySweden
-
University of North Carolina, Chapel HillRoche Pharma AGCompletedHepatitis C | Substance Use Disorders | Mental DisorderUnited States
-
Seoul National University HospitalRoche Pharma AG; SciClone PharmaceuticalsCompletedChronic Hepatitis BKorea, Republic of
-
Association Européenne de Recherche en OncologieRoche Pharma AGUnknownColorectal CancerFrance
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
University of BirminghamRoche Pharma AG; Cancer Research UKActive, not recruitingBreast CancerUnited Kingdom
-
Mario Negri Institute for Pharmacological ResearchRoche Pharma AGActive, not recruiting